ASIP Annual Meeting at Experimental Biology
Each year, ASIP meets with multiple biomedical research societies at the annual Experimental Biology (EB) meeting. The Experimental Biology meeting is among the largest biomedical/research meetings globally, and attracts 12,000 - 15,000 biomedical scientists annually.
The ASIP Annual Meeting at Experimental Biology features current topics in disease pathogenesis, including both mechanistic and translational aspects of pathology research. Programming includes several major symposia, workshops, educational sessions, award lectures, and other special sessions that feature nationally and internationally recognized investigators and speakers. Various aspects of professional growth and advancement are presented in career development workshops that specifically address the needs of MD, MD/PhD, PhD, and other trainees. Additional sessions are programmed from abstract submissions to the ASIP topic categories covering a wide variety of subjects related to pathogenesis research.
Pathobiology for Investigators, Students, and Academicians (PISA)
ASIP's stand alone meeting, Pathobiology for Investigators, Students, and Academicians (PISA) is aimed at delivering attendees the most exciting and up-to-date concepts in the field of pathobiology. The unique format of the PISA meeting mixes talks from world-renowned scientists with the hottest research in the field as pulled from the submitted abstracts. The PISA meeting also offers break-out poster discussions where you can network with researchers who are interested in your specific area of research. This new event has already earned a reputation of being collegial, collaborative, and cutting-edge. It will prove to be a necessary addition to the calendar of any research pathologist!
ASIP Summer Academy
Held from 2008-2010, the popular ASIP Summer Academy Course materials are available online, free of charge for ASIP members. Lectures are available as audio-synchronized presentations. There are no scheduled future ASIP Summer Academy courses at this time.